Published online 2 January 2004
Nucleic Acids Research, 2004, Vol. 32, No. 1 e1
© 2004 Oxford University Press
Dual-regulated expression of C/EBP-
and BMP-2 enables differential differentiation of C2C12 cells into adipocytes and osteoblasts
Institute of Biotechnology, Swiss Federal Institute of Technology, ETH Hoenggerberg, HPT D74, CH-8093 Zurich, Switzerland
*To whom correspondence should be addressed. Tel: +41 1 633 34 48; Fax: +41 1 633 12 34; Email: fussenegger{at}biotech.biol.ethz.ch
CCAAT/enhancer-binding proteins (C/EBPs) as well as bone morphogenic proteins (BMPs) play essential roles in mammalian cell differentiation in shaping adipogenic and osteoblastic lineages in particular. Recent evidence suggested that adipocytes and osteoblasts share a common mesenchymal precursor cell phenotype. Yet, the molecular details underlying the decision of adipocyte versus osteoblast differentiation as well as the involvement of C/EBPs and BMPs remains elusive. We have engineered C2C12 cells for dual-regulated expression of human C/EBP-
and BMP-2 to enable independent transcription control of both differentiation factors using clinically licensed antibiotics of the streptogramin (pristinamycin) and tetracycline (tetracycline) classes. Differential as well as coordinated expression of C/EBP- and BMP-2 revealed that (i) C/EBP- may differentiate C2C12 myoblasts into adipocytes as well as osteoblasts, (ii) BMP-2 prevents myotube differentiation, (iii) is incompetent in differentiating C2C12 into osteoblasts and (iv) even decreases C/EBP-’s osteoblast-specific differentiation potential but (v) cooperates with C/EBP- on adipocyte differentiation, (vi) osteoblast formation occurs at low C/EBP- levels while adipocyte-specific differentiation requires maximum C/EBP- expression and that (vii) BMP-2 may bias the C/EBP--mediated adipocyte versus osteoblast differentiation switch towards fat cell formation. Dual-regulated expression technology enabled precise insight into combinatorial effects of two key differentiation factors involved in adipocyte/osteoblast lineage control which could be implemented in rational reprogramming of multipotent cells into desired cell phenotypes tailored for gene therapy and tissue engineering.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  X. Shi and D. J. Garry Muscle stem cells in development, regeneration, and disease. Genes & Dev., July 1, 2006; 20(13): 1692 - 1708. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Harrison, Y.-F. Huang, K. A. Wilson, P. L. Kelly, D. J. Adams, G. A. Gronowicz, and S. H. Clark Col1a1 Promoter-targeted Expression of p20 CCAAT Enhancer-binding Protein {beta} (C/EBP{beta}), a Truncated C/EBP{beta} Isoform, Causes Osteopenia in Transgenic Mice J. Biol. Chem., March 4, 2005; 280(9): 8117 - 8124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Mitta, C. C. Weber, M. Rimann, and M. Fussenegger Design and in vivo characterization of self-inactivating human and non-human lentiviral expression vectors engineered for streptogramin-adjustable transgene expression Nucleic Acids Res., July 16, 2004; 32(12): e106 - e106. [Abstract] [Full Text] [PDF]
|
|